Search results
Eli Lilly Has a New Drug That Could Push the Stock Higher | The Motley Fool
The Motley Fool· 4 days agoThe stock of Eli Lilly (LLY -0.61%), the world's largest pharmaceutical company, keeps reaching new all-time highs, largely off the back of its weight loss and diabetes drugs, Zepbound and & ...
Nestle, Coke take cautious approach to catering to Ozempic users
Reuters via Yahoo Finance· 5 days agoNEW YORK (Reuters) -Nestle's new food brand for people taking weight-loss drugs like Wegovy will...
Nestle, Coke take cautious approach to catering to Ozempic users By Reuters
Investing.com· 5 days agoNEW YORK (Reuters) -Nestle's new food brand for people taking weight-loss drugs like Wegovy will...
Tirzepatide May Help Treat Sleep Apnea in People With Obesity
MedPage Today· 4 days agoTirzepatide (Zepbound) improved symptoms of moderate-to-severe obstructive sleep apnea (OSA) in...
Focus: Food companies with Ozempic-friendly snacks and meals wade carefully into weight-loss waters
Reuters· 5 days ago, opens new tab new food brand for people taking weight-loss drugs like Wegovy will note that the...
Gateway - Quartz
Quartz· 7 days agoHealthcare companies including Ro and Eli Lilly are introducing online supply trackers to help patients navigate ongoing GLP-1 drug shortages. Moderna says it is in talks about receiving U.S ...
Lilly's tirzepatide reduced obstructive sleep apnea (OSA) severity, with up to 51.5% of participants...
The Woonsocket Call· 3 days agoIn the primary endpoint, tirzepatide reduced moderate-to-severe OSA severity by up to 62.8% (about 30 fewer events per hour)